{
    "clinical_study": {
        "@rank": "45179", 
        "brief_summary": {
            "textblock": "The objectives of this study are:\n\n        1. To collect data necessary for assessing the performance of advanced Vaginal Tactile\n           Imager (VTI) and evaluating the probe ergonomic design, safety and patient tolerance;\n\n        2. To assess the clinical suitability of the interface software to facilitate the data\n           collection process and to get in vivo examination data for validation of visualization\n           and analysis routines;\n\n        3. To test the data collection technique and establish a reliable examination procedure."
        }, 
        "brief_title": "Study With Advanced Vaginal Tactile Imager", 
        "completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Investigative Techniques", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        Adult women (over the age of 21) falling within one of the following groups:\n\n          1. No evidence of pelvic floor disorder and no prior pelvic surgery;\n\n          2. Stage 1 or 2 pelvic organ prolapse affecting one or more vaginal compartment.\n\n        Exclusion Criteria:\n\n          1. Active skin infection or ulceration within the vagina\n\n          2. Presence of a vaginal septum;\n\n          3. Active cancer of the colon, rectum wall, cervix, vaginal, uterus or bladder;\n\n          4. Ongoing radiation therapy for pelvic cancer;\n\n          5. Impacted stool;\n\n          6. Recent (less than three months) pelvic surgery;\n\n          7. Significant pre-existing pelvic pain including levator ani syndrome, severe\n             vaginismus or vulvodynia;\n\n          8. Severe hemorrhoids;\n\n          9. Surgically absent rectum or bladder;\n\n         10. Significant circulatory or cardiac conditions that could cause excessive risk from\n             the examination as determined by attending physician."
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "21 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Adult females, presenting to the urogynecological office for a vaginal examination with\n        normal pelvic floor organs, referred to gynecologic examination due to pelvic organ\n        prolapse concern or earlier diagnosed with pelvic organ prolapse, will be considered\n        eligible as volunteers to be enrolled in the clinical studies."
            }
        }, 
        "enrollment": {
            "#text": "22", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 3, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01848626", 
            "org_study_id": "VTI 04"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "February 24, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Princeton", 
                    "country": "United States", 
                    "state": "New Jersey", 
                    "zip": "08540"
                }, 
                "name": "Princeton Urogynecology"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "Study With Advanced Vaginal Tactile Imager", 
        "overall_official": {
            "affiliation": "Artann Laboratories", 
            "last_name": "Vladimir Egorov, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Enrolling by invitation", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Imaging performance", 
            "safety_issue": "Yes", 
            "time_frame": "3 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01848626"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Artann Laboratories", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Artann Laboratories", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "April 2013", 
        "study_design": "Observational Model: Case Control, Time Perspective: Cross-Sectional", 
        "study_type": "Observational", 
        "verification_date": "February 2014"
    }
}